BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News

Cystic fibrosis News Articles

Get Our Industry eNewsletter FREE email:    
 Top Breaking News
These Mutated Cystic Fibrosis Cells are Worth Billions to Vertex Pharmaceuticals (MA)     6/17/2013   More...
Vertex Pharmaceuticals Incorporated Booms on Cystic Fibrosis Combo Drug Study     4/23/2013   More...
FDA Rejects Pharmaxis Ltd Drug Push Bid     3/19/2013   More...
Vertex Pharmaceuticals Incorporated Readies Late-Stage Cystic Fibrosis Drug Studies     2/27/2013   More...
Cystic Fibrosis Drug From Vertex Pharmaceuticals (MA) is Approved by Canadian Regulators     12/3/2012   More...
Pfizer Inc. Signs a $58 Million Agreement With Cystic Fibrosis Foundation Therapeutics, Inc.     11/20/2012   More...
Vertex Pharmaceuticals (MA) Cystic Fibrosis Drug Passes Key Test     10/16/2012   More...
FDA Panel Backs Novartis Pharmaceuticals Corporation's Cystic Fibrosis Drug     9/7/2012   More...
FDA Questions Novartis AG Cystic Fibrosis Drug     9/4/2012   More...
EU Approves Vertex Pharmaceuticals Incorporated's KALYDECO for Cystic Fibrosis     7/27/2012   More...
Vertex Pharmaceuticals Incorporated Offers More Evidence for Cystic Fibrosis Drug     6/29/2012   More...
Oops! Vertex Pharmaceuticals Incorporated Revises Cystic Fibrosis Combo Data     5/30/2012   More...
Vertex Pharmaceuticals (MA) Soars as Cystic Fibrosis Drug Regimen Improves Patients’ Breathing     5/8/2012   More...
Medical Research Council: $4.9 Million Boost for Ground Breaking Cystic Fibrosis Treatment     3/20/2012   More...
Forest Laboratories, Inc. Receives European Marketing Approval for Colobreathe® Dry Powder Inhaler     2/24/2012   More...
 Featured Stories
New Drug Target Found for Cystic Fibrosis Lung Disease, BC Children's Hospital Study     11/8/2012   More...
Sea Sponge Chemical Fixes Cystic Fibrosis Defect, McGill University Study     10/29/2012   More...
Differences Seen in Lung Microbes of Cystic Fibrosis Patients, Stanford University Study     10/1/2012   More...
Big Advance Against Cystic Fibrosis: Stem Cell Researchers Create Lung Surface Tissue in a Dish, Massachusetts General Hospital Study     4/6/2012   More...
Student, 16, Invents New Drug Cocktail to Fight Cystic Fibrosis, Wins Canadian Biotech Challenge, National Research Council of Canada laboratories Reveals     5/12/2011   More...
Cystic Fibrosis Patients May Benefit From Combination Therapy Which Provides Hope For Cure Of Dangerous Infections, McMaster University Study     4/25/2011   More...
New Cystic Fibrosis Drug Improves Lung Function, University of Colorado Study     12/22/2010   More...
Novel Drug Aids CF Kids' Lungs, University of Colorado Study     12/20/2010   More...
Drug Corrects CF Genetic Defect, University of Colorado Reveals     11/18/2010   More...
TOBI Reduces Mortality in Patients with Cystic Fibrosis, Pa Lung Infection, Children's Hospital Boston Study     10/22/2010   More...
One Step Closer to a Drug Treatment for Cystic Fibrosis, University of Missouri Professor Says     10/12/2010   More...
Growth Hormone May Benefit Lungs in CF, University of Connecticut/Hartford Hospital Evidence-Based Practice Center Study     10/7/2010   More...
MP-376 Safe and Effective for Treatment of P. Aeruginosa in CF Patients, University of California, San Diego (UCSD) Study Finds     5/17/2010   More...
New Drug May Treat Cystic Fibrosis, Other Diseases Caused By 'Nonsense Mutations', University of Alabama at Birmingham Study     4/27/2010   More...
University of Pennsylvania Study Finds that Antioxidant Found in Vegetables Has Implications for Treating Cystic Fibrosis     11/17/2009   More...
 More News
Integrated DNA Technologies Release: miRNA Regulated Networks Identified in Cystic Fibrosis     5/21/2013   More...
Proteostasis Therapeutics, Inc. Presents Preclinical Data on Parkinson’s Disease and Cystic Fibrosis Targets at EMBO Conference     5/21/2013   More...
Cornerstone Therapeutics Inc. Acquires Exclusive U.S. Marketing Rights to PERTZYE® (pancrelipase) for Treatment of Exocrine Pancreatic Insufficiency in Patients With Cystic Fibrosis     5/9/2013   More...
ERT, Johns Hopkins University and the University of Washington Expand Study on Effects of Home-Health Monitoring on Exacerbations of Cystic Fibrosis     2/4/2013   More...
Vertex Pharmaceuticals (MA) (VRTX) Release: Republic of Ireland Approves Funding for KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis, for People With a Specific Genetic Mutation (G551D)     2/1/2013   More...
Aptalis Pharmaceutical Technologies Announces Results of Phase 3 Studies of Aeroquin™ (Levofloxacin Solution for Inhalation) Among Patients With Cystic Fibrosis and Chronic Lung Infection     1/7/2013   More...
Vertex Pharmaceuticals (MA) (VRTX) Release: National Health Service in England Funds KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis, for People With a Specific Genetic Mutation (G551D)     12/19/2012   More...
Aptalis Pharmaceutical Technologies Announces U.S. Commercial Availability of ULTRESA™ (Pancrelipase) Delayed-Release Capsules     12/10/2012   More...
Savara' AeroVanc Granted U.S. Orphan Drug Designation for the Treatment of MRSA Lung Infection in Cystic Fibrosis Patients     11/13/2012   More...
Vertex Pharmaceuticals Incorporated (VRTX) Announces Presentation of Data at North American Cystic Fibrosis Conference     9/26/2012   More...
Cystic Fibrosis Foundation Therapeutics, Inc. and Pulmatrix Initiate Collaboration to Accelerate PUR118 in the Treatment of Cystic Fibrosis     9/14/2012   More...
Data From Follow-Up Study of Vertex Pharmaceuticals Incorporated (VRTX)' KALYDECO™ (ivacaftor) Showed Durable Improvements in Lung Function and Other Measures of Disease in People With Cystic Fibrosis Who Have a Specific Genetic Mutation (G551D)     6/8/2012   More...
GlobalData Release: Combination Therapy With Kalydeco and VX-809 in Cystic Fibrosis: Too Good to be True?     6/1/2012   More...
Vertex Pharmaceuticals (MA) (VRTX) Receives European CHMP Positive Opinion for KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis     5/25/2012   More...
Savara's AeroVanc for Cystic Fibrosis Patients Achieves Positive Results in Phase I Clinical Trial     4/26/2012   More...